The DOI matches its Crossref record; 381 of the 381 references it cites were found in a registry or an index.
National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Diagnosis and Management of Atrial Fibrillation 2018
Open accessAbstract
Australian Clinical Guidelines for the Diagnosis and Management of Atrial Fibrillation 2018" have been jointly developed by the Heart Foundation and the Cardiac Society of Australia and New Zealand.The Heart Foundation and the Cardiac Society of Australia and New Zealand are grateful for the contributions of all persons and entities involved
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
Crossing the Quality Chasm: A New Health System for the 21st Century
Committee on Quality of Health Care in America (2002) · Journal For Healthcare Quality · doi:10.1111/j.1945-1474.2002.tb00463.x · Cited by 8,483
Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins
Haïssaguerre, M., Jaïs, P., Shah, D. C., Takahashi, A., Hocini, M., Quiniou, G., Garrigue, S., Le Mouroux, A., Le Métayer, P., & Clémenty, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809033391003 · Cited by 7,975
Decision aids for people facing health treatment or screening decisions
Stacey, D., Légaré, F., Lewis, K., Barry, M. J., Bennett, C. L., Eden, K. B., Holmes-Rovner, M., Llewellyn-Thomas, H., Lyddiatt, A., Thomson, R., et al. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001431.pub5 · Cited by 6,685
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
Self-citationRuff, C. T., Giugliano, R. P., Braunwald, E., Hoffman, E. B., Deenadayalu, N., Ezekowitz, M. D., Camm, A. J., Weitz, J. I., Lewis, B. S., Parkhomenko, A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62343-0 · Cited by 5,051
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
Pisters, R., Lane, D. A., Nieuwlaat, R., de Vos, C. B., Crijns, H. J. G. M., & Lip, G. Y. H. (2010) · Chest · doi:10.1378/chest.10-0134 · Cited by 4,505
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332 · cited 6×
“Disopyramide, a Class Ia AAD, is often used to treat LVOT obstruction in combination with a rate-limiting medication (because it can increase AV nodal conduction), but its use to treat AF is not established [165,200].”
BackgroundInfluentialValgimigli, M., Bueno, H., Byrne, R. A., Collet, J.-P., Costa, F., Jeppsson, A., Jüni, P., Kastrati, A., Kolh, P., Mauri, L., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx419 · Cited by 2,987
Interventions for enhancing medication adherence
Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., Agoritsas, T., Mistry, N., Iorio, A., Jack, S., et al. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011.pub4 · Cited by 2,945 · cited 1×
“Unfortunately, the most effective interventions are usually complex (comprising tailored ongoing support, cognitive behavioural therapy, motivational interviewing, education, or daily treatment support; which are delivered face-to-face, often via pharmacists) and may be difficult to implement in real-world practice [4…”
Cappato, R., Calkins, H., Chen, S.-A., Davies, W., Iesaka, Y., Kalman, J., Kim, Y.-H., Klein, G., Natale, A., Packer, D., et al. (2010) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.109.859116 · Cited by 2,852 · cited 1×
“3% internationally, although they are thought to be lower in Australian practice [344].”
Miyasaka, Y., Barnes, M. E., Gersh, B. J., Cha, S. S., Bailey, K. R., Abhayaratna, W. P., Seward, J. B., & Tsang, T. S. M. (2006) · Circulation · doi:10.1161/circulationaha.105.595140 · Cited by 2,564
Catheter Ablation for Atrial Fibrillation with Heart Failure
Marrouche, N. F., Brachmann, J., Andresen, D., Siebels, J., Boersma, L., Jordaens, L., Merkely, B., Pokushalov, E., Sanders, P., Proff, J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1707855 · Cited by 2,492
Self-citationApixaban in patients with atrial fibrillation
Connolly, S. J., Eikelboom, J., Joyner, C., Diener, H.-C., Hart, R., Golitsyn, S., Flaker, G., Avezum, A., Hohnloser, S. H., Diaz, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007432 · Cited by 2,483 · cited 1×
“The evidence for stroke prevention with aspirin is weak [255,258], and it is not as benign as many think, with data suggesting that bleeding rates were similar to apixaban in patients with N-VAF who were deemed ineligible for anticoagulation with warfarin [259].”
Van Gelder, I. C., Hagens, V. E., Bosker, H. A., Kingma, J. H., Kamp, O., Kingma, T., Said, S. A., Darmanata, J. I., Timmermans, A. J. M., Tijssen, J. G. P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021375 · Cited by 2,359
Medication compliance and persistence: terminology and definitions
Cramer, J. A., Roy, A., Burrell, A., Fairchild, C. J., Fuldeore, M. J., Ollendorf, D. A., & Wong, P. K. (2008) · Value in Health · doi:10.1111/j.1524-4733.2007.00213.x · Cited by 2,220 · cited 2×
“discontinuation of therapy [399]) with it.”
BackgroundCryptogenic stroke and underlying atrial fibrillation
Sanna, T., Diener, H.-C., Passman, R. S., Di Lazzaro, V., Bernstein, R. A., Morillo, C. A., Rymer, M. M., Thijs, V., Rogers, T., Beckers, F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1313600 · Cited by 2,161
Steffel, J., Verhamme, P., Potpara, T. S., Albaladejo, P., Antz, M., Desteghe, L., Haeusler, K. G., Oldgren, J., Reinecke, H., Roldan-Schilling, V., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy136 · Cited by 2,123
Effect of clopidogrel added to aspirin in patients with atrial fibrillation
The ACTIVE Investigators (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901301 · Cited by 2,102 · cited 1×
“The combination antiplatelet therapy was 44% less effective than warfarin in stroke prevention, with comparable incidence of major bleeding [260].”
(1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420130036007 · Cited by 2,071
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000040 · Cited by 2,056
Holmes, D. R., Kar, S., Price, M. J., Whisenant, B., Sievert, H., Doshi, S. K., Huber, K., & Reddy, V. Y. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.04.029 · Cited by 1,845
Schnabel, R. B., Yin, X., Gona, P., Larson, M. G., Beiser, A. S., McManus, D. D., Newton-Cheh, C., Lubitz, S. A., Magnani, J. W., Ellinor, P. T., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61774-8 · Cited by 1,746
Dewilde, W. J., Oirbans, T., Verheugt, F. W., Kelder, J. C., De Smet, B. J., Herrman, J.-P., Adriaenssens, T., Vrolix, M., Heestermans, A. A., Vis, M. M., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62177-1 · Cited by 1,719 · cited 1×
“The What is the Optimal Antiplatelet and Anticoagulant Therapy in Patients with Oral Anticoagulation and Coronary Stenting (WOEST) trial showed that clopidogrel and warfarin caused less bleeding than triple therapy in patients undergoing stenting, and that there was less recurrent ischaemia and mortality with this str…”
Rhythm control versus rate control for atrial fibrillation and heart failure
Roy, D., Talajic, M., Nattel, S., Wyse, D. G., Dorian, P., Lee, K. L., Bourassa, M. G., Arnold, J. M. O., Buxton, A. E., Camm, A. J., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708789 · Cited by 1,585
Mant, J., Hobbs, F. R., Fletcher, K., Roalfe, A., Fitzmaurice, D., Lip, G. Y., & Murray, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61233-1 · Cited by 1,556 · cited 1×
“The use of OACs in a general practice RCT has demonstrated safety and benefit in older people, including those aged more than 85 years [315].”
Idarucizumab for Dabigatran Reversal
Pollack, C. V., Reilly, P. A., Eikelboom, J., Glund, S., Verhamme, P., Bernstein, R. A., Dubiel, R., Huisman, M. V., Hylek, E. M., Kamphuisen, P. W., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1502000 · Cited by 1,552
New Perspectives on the Prevalence of Hypertrophic Cardiomyopathy
Semsarian, C., Ingles, J., Maron, M. S., & Maron, B. J. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.01.019 · Cited by 1,384
Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation
Cannon, C. P., Bhatt, D. L., Oldgren, J., Lip, G. Y. H., Ellis, S. G., Kimura, T., Maeng, M., Merkely, B., Zeymer, U., Gropper, S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1708454 · Cited by 1,383
Promotion of Atrial Fibrillation by Heart Failure in Dogs: Atrial Remodeling of a Different Sort
Li, D., Fareh, S., Leung, T. K., & Nattel, S. (1999) · Circulation · doi:10.1161/01.cir.100.1.87 · Cited by 1,341
Effect of Intensity of Oral Anticoagulation on Stroke Severity and Mortality in Atrial Fibrillation
Hylek, E. M., Go, A. S., Chang, Y., Jensvold, N. G., Henault, L. E., Selby, J. V., & Singer, D. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022913 · Cited by 1,277
Pathophysiological mechanisms of atrial fibrillation: a translational appraisal
Schotten, U., Verheule, S., Kirchhof, P., & Goette, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00031.2009 · Cited by 1,273 · cited 1×
“The more risk factors that an individual has, the greater the likelihood that a person will develop AF and more persistent AF [90,91].”
Clopidogrel with or without Omeprazole in Coronary Artery Disease
Bhatt, D. L., Cryer, B. L., Contant, C. F., Cohen, M., Lanas, A., Schnitzer, T. J., Shook, T. L., Lapuerta, P., Goldsmith, M. A., Laine, L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007964 · Cited by 1,240
Chen, Z.-M. (1997) · The Lancet · doi:10.1016/s0140-6736(97)04010-5 · Cited by 1,232
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
Douketis, J. D., Spyropoulos, A. C., Kaatz, S., Becker, R. C., Caprini, J. A., Dunn, A. S., Garcia, D. A., Jacobson, A., Jaffer, A. K., Kong, D. F., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501035 · Cited by 1,184 · cited 2×
“The Bridging Anticoagulation in Patients Who Require Temporary Interruption of Warfarin Therapy for an Elective Invasive Procedure or Surgery (BRIDGE) trial evaluated this strategy in AF patients receiving warfarin with at least one risk factor for stroke (but no recent stroke or TIA) undergoing non-cardiac surgical p…”
Calkins, H., Hindricks, G., Cappato, R., Kim, Y.-H., Saad, E. B., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, J., et al. (2018) · EP Europace · doi:10.1093/europace/eux274 · Cited by 1,164
Self-citationWarfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation
Ezekowitz, M. D., Bridgers, S. L., James, K. E., Carliner, N. H., Colling, C. L., Gornick, C. C., Krause-Steinrauf, H., Kurtzke, J. F., Nazarian, S. M., Radford, M. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211123272002 · Cited by 1,160
Amiodarone to Prevent Recurrence of Atrial Fibrillation
Roy, D., Talajic, M., Dorian, P., Connolly, S., Eisenberg, M. J., Green, M., Kus, T., Lambert, J., Dubuc, M., Gagné, P., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421302 · Cited by 1,143
Hohnloser, S. H., Kuck, K.-H., & Lilienthal, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03230-x · Cited by 1,134
Obstructive Sleep Apnea, Obesity, and the Risk of Incident Atrial Fibrillation
Gami, A. S., Hodge, D. O., Herges, R. M., Olson, E. J., Nykodym, J., Kara, T., & Somers, V. K. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.060 · Cited by 1,104
Eikelboom, J. W., Wallentin, L., Connolly, S. J., Ezekowitz, M., Healey, J. S., Oldgren, J., Yang, S., Alings, M., Kaatz, S., Hohnloser, S. H., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.004747 · Cited by 1,081 · cited 1×
“Although data from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) study suggested dabigatran has acceptable safety and efficacy in the elderly when compared to warfarin [318,319], other cohort studies [320–322] suggest an increased GI bleeding risk.”
Abhayaratna, W. P., Seward, J. B., Appleton, C. P., Douglas, P. S., Oh, J. K., Tajik, A. J., & Tsang, T. S. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.02.048 · Cited by 1,076
The role of patient care teams in chronic disease management
Wagner, E. H. (2000) · BMJ · doi:10.1136/bmj.320.7234.569 · Cited by 1,047
Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort
Pathak, R. K., Middeldorp, M. E., Meredith, M., Mehta, A. B., Mahajan, R., Wong, C. X., Twomey, D., Elliott, A. D., Kalman, J. M., Abhayaratna, W. P., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.03.002 · Cited by 1,036 · cited 1×
“The response is graded—the greater the weight loss, the more the likelihood that the sinus rhythm will be maintained [100].”
Lenient versus strict rate control in patients with atrial fibrillation
Van Gelder, I. C., Groenveld, H. F., Crijns, H. J. G. M., Tuininga, Y. S., Tijssen, J. G. P., Alings, A. M., Hillege, H. L., Bergsma-Kadijk, J. A., Cornel, J. H., Kamp, O., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001337 · Cited by 1,033 · cited 1×
“rate target (<80 bpm resting and <110 bpm during moderate exertion) in 614 patients with permanent AF [125].”
Reddy, V. Y., Sievert, H., Halperin, J., Doshi, S. K., Buchbinder, M., Neuzil, P., Huber, K., Whisenant, B., Kar, S., Swarup, V., et al. (2014) · JAMA · doi:10.1001/jama.2014.15192 · Cited by 1,018
Gage, B. F., Yan, Y., Milligan, P. E., Waterman, A. D., Culverhouse, R., Rich, M. W., & Radford, M. J. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.04.017 · Cited by 1,008
KCNQ1 Gain-of-Function Mutation in Familial Atrial Fibrillation
Chen, Y.-H., Xu, S.-J., Bendahhou, S., Wang, X.-L., Wang, Y., Xu, W.-Y., Jin, H.-W., Sun, H., Su, X.-Y., Zhuang, Q.-N., et al. (2003) · Science · doi:10.1126/science.1077771 · Cited by 1,000
Variants conferring risk of atrial fibrillation on chromosome 4q25
Gudbjartsson, D. F., Arnar, D. O., Helgadottir, A., Gretarsdottir, S., Holm, H., Sigurdsson, A., Jonasdottir, A., Baker, A., Thorleifsson, G., Kristjansson, K., et al. (2007) · Nature · doi:10.1038/nature06007 · Cited by 955 · cited 1×
“Themost significantly associated variant associated with AF is the paired-like homeodomain 2 transcription factor (PITX2) on chromosome 4q25 locus [41].”
Use of Transesophageal Echocardiography to Guide Cardioversion in Patients with Atrial Fibrillation
Klein, A. L., Grimm, R. A., Murray, R. D., Apperson-Hansen, C., Asinger, R. W., Black, I. W., Davidoff, R., Erbel, R., Halperin, J. L., Orsinelli, D. A., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105103441901 · Cited by 951
Pathak, R. K., Middeldorp, M. E., Lau, D. H., Mehta, A. B., Mahajan, R., Twomey, D., Alasady, M., Hanley, L., Antic, N. A., McEvoy, R. D., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.028 · Cited by 949 · cited 1×
“In addition, in patients undergoing catheter ablation, aggressive management of risk factors has been associated with a significantly greater chance of remaining in sinus rhythm [99].”
Self-citationCoplen, S. E., Antman, E. M., Berlin, J. A., Hewitt, P., & Chalmers, T. C. (1990) · Circulation · doi:10.1161/01.cir.82.4.1106 · Cited by 945
Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation
Carlsson, J. Ö., Miketic, S., Windeler, J. Ü., Cuneo, A., Haun, S., Micus, S., Walter, S., & Tebbe, U. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00332-2 · Cited by 941
Stroke and bleeding in atrial fibrillation with chronic kidney disease
Olesen, J. B., Lip, G. Y. H., Kamper, A.-L., Hommel, K., Køber, L., Lane, D. A., Lindhardsen, J., Gislason, G. H., & Torp-Pedersen, C. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105594 · Cited by 930
Di Biase, L., Mohanty, P., Mohanty, S., Santangeli, P., Trivedi, C., Lakkireddy, D., Reddy, M., Jais, P., Themistoclakis, S., Dello Russo, A., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.019406 · Cited by 867
Hansen, M. L., Sørensen, R., Clausen, M. T., Fog-Petersen, M. L., Raunsø, J., Gadsbøll, N., Gislason, G. H., Folke, F., Andersen, S. S., Schramm, T. K., et al. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.271 · Cited by 855 · cited 1×
“Several case series have suggested that it is safe to continue warfarin through the angiographic procedure [335,336].”
A New Risk Scheme to Predict Warfarin-Associated Hemorrhage
Fang, M. C., Go, A. S., Chang, Y., Borowsky, L. H., Pomernacki, N. K., Udaltsova, N., & Singer, D. E. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.03.031 · Cited by 852
Healey, J. S., Baranchuk, A., Crystal, E., Morillo, C. A., Garfinkle, M., Yusuf, S., & Connolly, S. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.11.070 · Cited by 822
Abed, H. S., Wittert, G. A., Leong, D. P., Shirazi, M. G., Bahrami, B., Middeldorp, M. E., Lorimer, M. F., Lau, D. H., Antic, N. A., Brooks, A. G., et al. (2013) · JAMA · doi:10.1001/jama.2013.280521 · Cited by 776
Amiodarone versus sotalol for atrial fibrillation
Singh, B. N., Singh, S. N., Reda, D. J., Tang, X. C., Lopez, B., Harris, C. L., Fletcher, R. D., Sharma, S. C., Atwood, J. E., Jacobson, A. K., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041705 · Cited by 749
Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy
Olivotto, I., Cecchi, F., Casey, S. A., Dolara, A., Traverse, J. H., & Maron, B. J. (2001) · Circulation · doi:10.1161/hc4601.097997 · Cited by 745
Quality of life in patients with atrial fibrillation: a systematic review
Thrall, G., Lane, D., Carroll, D., & Lip, G. Y. H. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.10.057 · Cited by 697 · cited 1×
“AF is independently associated with an increased longterm risk of stroke, heart failure and all-cause death [3–5], and often leads to an impaired quality of life [10].”
Chow, C. K., Redfern, J., Hillis, G. S., Thakkar, J., Santo, K., Hackett, M. L., Jan, S., Graves, N., de Keizer, L., Barry, T., et al. (2015) · JAMA · doi:10.1001/jama.2015.10945 · Cited by 676
Mechanisms, Prevention, and Treatment of Atrial Fibrillation After Cardiac Surgery
Echahidi, N., Pibarot, P., O’Hara, G., & Mathieu, P. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.10.043 · Cited by 676
Catheter Ablation Versus Medical Rate Control in Atrial Fibrillation and Systolic Dysfunction
Prabhu, S., Taylor, A. J., Costello, B. T., Kaye, D. M., McLellan, A. J. A., Voskoboinik, A., Sugumar, H., Lockwood, S. M., Stokes, M. B., Pathik, B., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.08.041 · Cited by 648
Self-citationLai, K. C., Lam, S. K., Chu, K. M., Wong, B. C. Y., Hui, W. M., Hu, W. H. C., Lau, G. K. K., Wong, W. M., Yuen, M. F., Chan, A. O. O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012877 · Cited by 646
Atrial fibrillation: Profile and burden of an evolving epidemic in the 21st century
Ball, J., Carrington, M. J., McMurray, J. J. V., & Stewart, S. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.12.093 · Cited by 630
Clopidogrel versus Aspirin and Esomeprazole to Prevent Recurrent Ulcer Bleeding
Chan, F. K. L., Ching, J. Y. L., Hung, L. C. T., Wong, V. W. S., Leung, V. K. S., Kung, N. N. S., Hui, A. J., Wu, J. C. Y., Leung, W. K., Lee, V. W. Y., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042087 · Cited by 629
Sanders, P., Morton, J. B., Davidson, N. C., Spence, S. J., Vohra, J. K., Sparks, P. B., & Kalman, J. M. (2003) · Circulation · doi:10.1161/01.cir.0000090688.49283.67 · Cited by 622
Self-citationSTROKEPREVENTIONINATRIALFIBRIL (1994) · The Lancet · doi:10.1016/s0140-6736(94)91577-6 · Cited by 621
Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study
Svennberg, E., Engdahl, J., Al-Khalili, F., Friberg, L., Frykman, V., & Rosenqvist, M. (2015) · Circulation · doi:10.1161/circulationaha.114.014343 · Cited by 605
Modifiable Risk Factors and Atrial Fibrillation
Lau, D. H., Nattel, S., Kalman, J. M., & Sanders, P. (2017) · Circulation · doi:10.1161/circulationaha.116.023163 · Cited by 593
Self-citationCost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK
Stewart, S., Murphy, N., Walker, A., McGuire, A., & McMurray, J. J. V. (2004) · Heart · doi:10.1136/hrt.2002.008748 · Cited by 590
Deshmukh, A., Patel, N. J., Pant, S., Shah, N., Chothani, A., Mehta, K., Grover, P., Singh, V., Vallurupalli, S., Savani, G. T., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.003862 · Cited by 581
Task Force Members, Lip, G. Y. H., Windecker, S., Huber, K., Kirchhof, P., Marin, F., Ten Berg, J. M., Haeusler, K. G., Boriani, G., Capodanno, D., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu298 · Cited by 566
Pathak, R. K., Elliott, A., Middeldorp, M. E., Meredith, M., Mehta, A. B., Mahajan, R., Hendriks, J. M. L., Twomey, D., Kalman, J. M., Abhayaratna, W. P., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.06.488 · Cited by 544 · cited 1×
“Similar findings have been reported for physical activity levels [101].”
Healey, J. S., Eikelboom, J., Douketis, J., Wallentin, L., Oldgren, J., Yang, S., Themeles, E., Heidbuchel, H., Avezum, A., Reilly, P., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.090464 · Cited by 541
Man-Son-Hing, M., Nichol, G., Lau, A., & Laupacis, A. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.7.677 · Cited by 538
Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration
Freedman, B., Camm, J., Calkins, H., Healey, J. S., Rosenqvist, M., Wang, J., Albert, C. M., Anderson, C. S., Antoniou, S., Benjamin, E. J., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.026693 · Cited by 537
Self-citationNagarakanti, R., Ezekowitz, M. D., Oldgren, J., Yang, S., Chernick, M., Aikens, T. H., Flaker, G., Brugada, J., Kamenský, G., Parekh, A., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.977546 · Cited by 526
Hunter, R. J., Berriman, T. J., Diab, I., Kamdar, R., Richmond, L., Baker, V., Goromonzi, F., Sawhney, V., Duncan, E., Page, S. P., et al. (2014) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.113.000806 · Cited by 505
The Long- and Short-Term Impact of Elevated Body Mass Index on the Risk of New Atrial Fibrillation
Tedrow, U. B., Conen, D., Ridker, P. M., Cook, N. R., Koplan, B. A., Manson, J. E., Buring, J. E., & Albert, C. M. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.02.029 · Cited by 500
Hijazi, Z., Oldgren, J., Lindbäck, J., Alexander, J. H., Connolly, S. J., Eikelboom, J. W., Ezekowitz, M. D., Held, C., Hylek, E. M., Lopes, R. D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00741-8 · Cited by 490
Di Biase, L., Burkhardt, J. D., Santangeli, P., Mohanty, P., Sanchez, J. E., Horton, R., Gallinghouse, G. J., Themistoclakis, S., Rossillo, A., Lakkireddy, D., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.006426 · Cited by 485
Arrhythmia and Mortality After the Mustard Procedure: A 30-Year Single-Center Experience
Gelatt, M., Hamilton, R. M., McCrindle, B. W., Connelly, M., Davis, A., Harris, L., Gow, R. M., Williams, W. G., Trusler, G. A., & Freedom, R. M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00424-x · Cited by 483
Mozaffarian, D., Furberg, C. D., Psaty, B. M., & Siscovick, D. (2008) · Circulation · doi:10.1161/circulationaha.108.785626 · Cited by 476
Stroke prevention in atrial fibrillation
Freedman, B., Potpara, T. S., & Lip, G. Y. H. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31257-0 · Cited by 463
Self-citationMahajan, R., Lau, D. H., Brooks, A. G., Shipp, N. J., Manavis, J., Wood, J. P. M., Finnie, J. W., Samuel, C. S., Royce, S. G., Twomey, D. J., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.04.058 · Cited by 459
Self-citationLowres, N., Neubeck, L., Salkeld, G., Krass, I., McLachlan, A. J., Redfern, J., Bennett, A. A., Briffa, T., Bauman, A., Martinez, C., et al. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-03-0231 · Cited by 458
Self-citationYao, X., Abraham, N. S., Alexander, G. C., Crown, W., Montori, V. M., Sangaralingham, L. R., Gersh, B. J., Shah, N. D., & Noseworthy, P. A. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.003074 · Cited by 452
Andersson, T., Magnuson, A., Bryngelsson, I.-L., Frøbert, O., Henriksson, K. M., Edvardsson, N., & Poçi, D. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs469 · Cited by 449
Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study
Andersen, K., Farahmand, B., Ahlbom, A., Held, C., Ljunghall, S., Michaëlsson, K., & Sundström, J. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht188 · Cited by 448
Fein, A. S., Shvilkin, A., Shah, D., Haffajee, C. I., Das, S., Kumar, K., Kramer, D. B., Zimetbaum, P. J., Buxton, A. E., Josephson, M. E., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.03.052 · Cited by 447
The surgical treatment of atrial fibrillation
Cox, J. L. (1991) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)36685-1 · Cited by 445
The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation
O'Brien, E. C., Simon, D. N., Thomas, L. E., Hylek, E. M., Gersh, B. J., Ansell, J. E., Kowey, P. R., Mahaffey, K. W., Chang, P., Fonarow, G. C., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv476 · Cited by 440
Hobbs, F., Fitzmaurice, D., Mant, J., Murray, E., Jowett, S., Bryan, S., Raftery, J., Davies, M., & Lip, G. (2005) · Health Technology Assessment · doi:10.3310/hta9400 · Cited by 437
Hijazi, Z., Lindbäck, J., Alexander, J. H., Hanna, M., Held, C., Hylek, E. M., Lopes, R. D., Oldgren, J., Siegbahn, A., Stewart, R. A. H., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw054 · Cited by 437
Halperin, J. L., Hankey, G. J., Wojdyla, D. M., Piccini, J. P., Lokhnygina, Y., Patel, M. R., Breithardt, G., Singer, D. E., Becker, R. C., Hacke, W., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005008 · Cited by 431
Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation
Calkins, H., Willems, S., Gerstenfeld, E. P., Verma, A., Schilling, R., Hohnloser, S. H., Okumura, K., Serota, H., Nordaby, M., Guiver, K., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1701005 · Cited by 430
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
Lafuente-Lafuente, C., Valembois, L., Bergmann, J.-F., & Belmin, J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005049.pub4 · Cited by 423
Cappato, R., Marchlinski, F. E., Hohnloser, S. H., Naccarelli, G. V., Xiang, J., Wilber, D. J., Ma, C.-S., Hess, S., Wells, D. S., Juang, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv177 · Cited by 422
Prevention of Atrial Fibrillation by Renin-Angiotensin System Inhibition
Schneider, M. P., Hua, T. A., Böhm, M., Wachtell, K., Kjeldsen, S. E., & Schmieder, R. E. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.043 · Cited by 417 · cited 2×
“Treating underlying disease state has been observed to reduce incident AF, particularly in cohorts with heart failure [102,103].”
Natale, A., Newby, K. H., Pisanó, E., Leonelli, F., Fanelli, R., Potenza, D., Beheiry, S., & Tomassoni, G. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00635-5 · Cited by 414
Sherrid, M. V., Barac, I., McKenna, W. J., Elliott, P. M., Dickie, S., Chojnowska, L., Casey, S., & Maron, B. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.012 · Cited by 410 · cited 2×
“Disopyramide, a Class Ia AAD, is often used to treat LVOT obstruction in combination with a rate-limiting medication (because it can increase AV nodal conduction), but its use to treat AF is not established [165,200].”
Hendriks, J. M. L., de Wit, R., Crijns, H. J. G. M., Vrijhoef, H. J. M., Prins, M. H., Pisters, R., Pison, L. A. F. G., Blaauw, Y., & Tieleman, R. G. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs071 · Cited by 409
Fitzmaurice, D. A., Hobbs, F. D. R., Jowett, S., Mant, J., Murray, E. T., Holder, R., Raftery, J. P., Bryan, S., Davies, M., Lip, G. Y. H., et al. (2007) · BMJ · doi:10.1136/bmj.39280.660567.55 · Cited by 405
Larsen, T. B., Rasmussen, L. H., Skjøth, F., Due, K. M., Callréus, T., Rosenzweig, M., & Lip, G. Y. H. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.03.020 · Cited by 403
Abed, H. S., Samuel, C. S., Lau, D. H., Kelly, D. J., Royce, S. G., Alasady, M., Mahajan, R., Kuklik, P., Zhang, Y., Brooks, A. G., et al. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2012.08.043 · Cited by 400
Self-citationRate Control versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery
Gillinov, A. M., Bagiella, E., Moskowitz, A. J., Raiten, J. M., Groh, M. A., Bowdish, M. E., Ailawadi, G., Kirkwood, K. A., Perrault, L. P., Parides, M. K., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602002 · Cited by 398 · cited 1×
“a survival benefit following restoration of the sinus rhythm following cardiovascular surgery [213,215,217], the most recent RCT that studied the effectiveness and safety of rate control versus rhythm control after cardiothoracic surgery showed equal duration of hospital stay and complications [218].”
Primary Care: Concept, Evaluation, and Policy
Reader, G. G., & Starfield, B. (1993) · Journal of Public Health Policy · doi:10.2307/3342881 · Cited by 398
Wolf, R. K., Schneeberger, E. W., Osterday, R., Miller, D., Merrill, W., Flege, J. B., & Gillinov, A. M. (2005) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2005.03.041 · Cited by 392
Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy
Maron, B. J., Olivotto, I., Bellone, P., Conte, M. R., Cecchi, F., Flygenring, B. P., Casey, S. A., Gohman, T. E., Bongioanni, S., & Spirito, P. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01727-2 · Cited by 392
Tisdale, J. E., Jaynes, H. A., Kingery, J. R., Mourad, N. A., Trujillo, T. N., Overholser, B. R., & Kovacs, R. J. (2013) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.113.000152 · Cited by 385
Sudden cardiac death in adult congenital heart disease
Koyak, Z., Harris, L., de Groot, J. R., Silversides, C. K., Oechslin, E. N., Bouma, B. J., Budts, W., Zwinderman, A. H., Van Gelder, I. C., & Mulder, B. J. M. (2012) · Circulation · doi:10.1161/circulationaha.112.104786 · Cited by 378
The 1998 NASPE Prospective Catheter Ablation Registry
SCHEINMAN, M. M., & HUANG, S. (2000) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2000.tb00891.x · Cited by 374
Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation
Cappato, R., Ezekowitz, M. D., Klein, A. L., Camm, A. J., Ma, C.-S., Le Heuzey, J.-Y., Talajic, M., Scanavacca, M., Vardas, P. E., Kirchhof, P., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu367 · Cited by 372
Halvorsen, S., Atar, D., Yang, H., De Caterina, R., Erol, C., Garcia, D., Granger, C. B., Hanna, M., Held, C., Husted, S., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu046 · Cited by 370
Medication adherence outcomes of 771 intervention trials: Systematic review and meta-analysis
Conn, V. S., & Ruppar, T. M. (2017) · Preventive Medicine · doi:10.1016/j.ypmed.2017.03.008 · Cited by 367 · cited 1×
“, habit-based interventions), in preference to cognitive strategies targeting knowledge and beliefs [412].”
Martin, D. T., Bersohn, M. M., Waldo, A. L., Wathen, M. S., Choucair, W. K., Lip, G. Y. H., Ip, J., Holcomb, R., Akar, J. G., & Halperin, J. L. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv115 · Cited by 364
Guttmann, O. P., Rahman, M. S., O'Mahony, C., Anastasakis, A., & Elliott, P. M. (2014) · Heart · doi:10.1136/heartjnl-2013-304276 · Cited by 356
Perioperative atrial fibrillation and the long-term risk of ischemic stroke
Gialdini, G., Nearing, K., Bhave, P. D., Bonuccelli, U., Iadecola, C., Healey, J. S., & Kamel, H. (2014) · JAMA · doi:10.1001/jama.2014.9143 · Cited by 355
Chamberlain, A. M., Agarwal, S. K., Folsom, A. R., Soliman, E. Z., Chambless, L. E., Crow, R., Ambrose, M., & Alonso, A. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.08.049 · Cited by 354 · cited 1×
“The more risk factors that an individual has, the greater the likelihood that a person will develop AF and more persistent AF [90,91].”
Atrial flutter in the young: A collaborative study of 380 cases
Garson, A., Bink-Boelkens, M., Hesslein, P. S., Hordof, A. J., Keane, J. F., Neches, W. H., & Porter, C.-B. J. (1985) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(85)80497-6 · Cited by 348
Ziff, O. J., Lane, D. A., Samra, M., Griffith, M., Kirchhof, P., Lip, G. Y. H., Steeds, R. P., Townend, J., & Kotecha, D. (2015) · BMJ · doi:10.1136/bmj.h4451 · Cited by 341 · cited 20×
“The evidence for flecainide for acute (rapid) conversion to sinus rhythm is based on several RCTs of modest size and one meta-analysis [138–142].”
InfluentialObesity and the Risk of Incident, Post-Operative, and Post-Ablation Atrial Fibrillation
Wong, C. X., Sullivan, T., Sun, M. T., Mahajan, R., Pathak, R. K., Middeldorp, M., Twomey, D., Ganesan, A. N., Rangnekar, G., Roberts-Thomson, K. C., et al. (2015) · JACC: Clinical Electrophysiology · doi:10.1016/j.jacep.2015.04.004 · Cited by 338
Self-citationBoriani, G., Laroche, C., Diemberger, I., Fantecchi, E., Popescu, M. I., Rasmussen, L. H., Sinagra, G., Petrescu, L., Tavazzi, L., Maggioni, A. P., et al. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.11.026 · Cited by 338
Stangier, J., & Clemens, A. (2009) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029609343004 · Cited by 337
Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial
FETSCH, T. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.04.015 · Cited by 334
Screening to identify unknown atrial fibrillation: A systematic review
Lowres, N., Neubeck, L., Redfern, J., & Freedman, S. B. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-02-0165 · Cited by 327
Atrial remodeling in obstructive sleep apnea: Implications for atrial fibrillation
Dimitri, H., Ng, M., Brooks, A. G., Kuklik, P., Stiles, M. K., Lau, D. H., Antic, N., Thornton, A., Saint, D. A., McEvoy, D., et al. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2011.10.017 · Cited by 326
Self-citationParoxysmal Lone Atrial Fibrillation Is Associated With an Abnormal Atrial Substrate
Stiles, M. K., John, B., Wong, C. X., Kuklik, P., Brooks, A. G., Lau, D. H., Dimitri, H., Roberts-Thomson, K. C., Wilson, L., De Sciscio, P., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.054 · Cited by 325
Self-citationAssociation Between Familial Atrial Fibrillation and Risk of New-Onset Atrial Fibrillation
Lubitz, S. A., Yin, X., Fontes, J. D., Magnani, J. W., Rienstra, M., Pai, M., Villalon, M. L., Vasan, R. S., Pencina, M. J., Levy, D., et al. (2010) · JAMA · doi:10.1001/jama.2010.1690 · Cited by 313
Paciaroni, M., Agnelli, G., Micheli, S., & Caso, V. (2007) · Stroke · doi:10.1161/01.str.0000254600.92975.1f · Cited by 307
Pérez, F. J., Schubert, C. M., Parvez, B., Pathak, V., Ellenbogen, K. A., & Wood, M. A. (2009) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.109.871665 · Cited by 303
Atrial Fibrillation Promotion by Endurance Exercise
Guasch, E., Benito, B., Qi, X., Cifelli, C., Naud, P., Shi, Y., Mighiu, A., Tardif, J.-C., Tadevosyan, A., Chen, Y., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.01.091 · Cited by 302
(1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.12.1316 · Cited by 302
Kay, G. N., Ellenbogen, K. A., Giudici, M., Redfield, M. M., Jenkins, L. S., Mianulli, M., & Wilkoff, B. (1998) · Journal of Interventional Cardiac Electrophysiology · doi:10.1023/a:1009795330454 · Cited by 298
Kralev, S., Schneider, K., Lang, S., Süselbeck, T., & Borggrefe, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024964 · Cited by 295
Lopes, R. D., Alings, M., Connolly, S. J., Beresh, H., Granger, C. B., Mazuecos, J. B., Boriani, G., Nielsen, J. C., Conen, D., Hohnloser, S. H., et al. (2017) · American Heart Journal · doi:10.1016/j.ahj.2017.04.008 · Cited by 290
Anderson, J. L., Gilbert, E. M., Alpert, B. L., Henthorn, R. W., Waldo, A. L., Bhandari, A. K., Hawkinson, R. W., & Pritchett, E. L. (1989) · Circulation · doi:10.1161/01.cir.80.6.1557 · Cited by 287
Bonde, A. N., Lip, G. Y. H., Kamper, A.-L., Hansen, P. R., Lamberts, M., Hommel, K., Hansen, M. L., Gislason, G. H., Torp-Pedersen, C., & Olesen, J. B. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.051 · Cited by 285
Sanders, P., Morton, J. B., Kistler, P. M., Spence, S. J., Davidson, N. C., Hussin, A., Vohra, J. K., Sparks, P. B., & Kalman, J. M. (2004) · Circulation · doi:10.1161/01.cir.0000121734.47409.aa · Cited by 285
Self-citationLamberts, M., Gislason, G. H., Lip, G. Y. H., Lassen, J. F., Olesen, J. B., Mikkelsen, A. P., Sørensen, R., Køber, L., Torp-Pedersen, C., & Hansen, M. L. (2014) · Circulation · doi:10.1161/circulationaha.113.004834 · Cited by 284
Ho, P. M., Lambert-Kerzner, A., Carey, E. P., Fahdi, I. E., Bryson, C. L., Melnyk, S. D., Bosworth, H. B., Radcliff, T., Davis, R., Mun, H., et al. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.12944 · Cited by 282
Winkelmayer, W. C., Liu, J., Setoguchi, S., & Choudhry, N. K. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04550511 · Cited by 280
Siontis, K. C., Geske, J. B., Ong, K., Nishimura, R. A., Ommen, S. R., & Gersh, B. J. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001002 · Cited by 276
Mahajan, R., Perera, T., Elliott, A. D., Twomey, D. J., Kumar, S., Munwar, D. A., Khokhar, K. B., Thiyagarajah, A., Middeldorp, M. E., Nalliah, C. J., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx731 · Cited by 275
Self-citationNaruse, Y., Tada, H., Satoh, M., Yanagihara, M., Tsuneoka, H., Hirata, Y., Ito, Y., Kuroki, K., Machino, T., Yamasaki, H., et al. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2012.11.015 · Cited by 267 · cited 1×
“For example, an increasing amount of data suggests that treatment of sleep apnoea improves the maintenance of sinus rhythm in rhythm-control strategies [94,95].”
Sherwood, M. W., Douketis, J. D., Patel, M. R., Piccini, J. P., Hellkamp, A. S., Lokhnygina, Y., Spyropoulos, A. C., Hankey, G. J., Singer, D. E., Nessel, C. C., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.005754 · Cited by 267
Malmo, V., Nes, B. M., Amundsen, B. H., Tjonna, A.-E., Stoylen, A., Rossvoll, O., Wisloff, U., & Loennechen, J. P. (2016) · Circulation · doi:10.1161/circulationaha.115.018220 · Cited by 263 · cited 1×
“This has been observed in a small randomised study that evaluated the role of exercise intervention [104].”
Galve, E., Rius, T., Ballester, R., Artaza, M. A., Arnau, J. M., García-Dorado, D., & Soler-Soler, J. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00595-1 · Cited by 263
Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy
Rowin, E. J., Hausvater, A., Link, M. S., Abt, P., Gionfriddo, W., Wang, W., Rastegar, H., Estes, N. A. M., Maron, M. S., & Maron, B. J. (2017) · Circulation · doi:10.1161/circulationaha.117.029267 · Cited by 262
Thromboembolic Complications After Cardioversion of Acute Atrial Fibrillation
Airaksinen, K. E. J., Grönberg, T., Nuotio, I., Nikkinen, M., Ylitalo, A., Biancari, F., & Hartikainen, J. E. K. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.04.089 · Cited by 258 · cited 2×
“The associated risk of thromboembolism (leading to stroke or systemic embolism) is high, both at the time of the cardioversion and for some weeks afterwards [337,338].”
Kühlkamp, V., Schirdewan, A., Stangl, K., Homberg, M., Ploch, M., & Beck, O. A. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00693-8 · Cited by 256
Santo, K., Richtering, S. S., Chalmers, J., Thiagalingam, A., Chow, C. K., & Redfern, J. (2016) · JMIR mHealth and uHealth · doi:10.2196/mhealth.6742 · Cited by 256
Postoperative atrial fibrillation in non‐cardiac and cardiac surgery: an overview
Bessissow, A., Khan, J., Devereaux, P. J., Alvarez‐Garcia, J., & Alonso‐Coello, P. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12974 · Cited by 255
Chapman, N., Huxley, R., Anderson, C., Bousser, M. G., Chalmers, J., Colman, S., Davis, S., Donnan, G., MacMahon, S., Neal, B., et al. (2004) · Stroke · doi:10.1161/01.str.0000106480.76217.6f · Cited by 252
Roos-Hesselink, J., Perlroth, M. G., McGhie, J., & Spitaels, S. (1995) · Circulation · doi:10.1161/01.cir.91.8.2214 · Cited by 248
Gorenek, B., Bax, J., Boriani, G., Chen, S.-A., Dagres, N., Glotzer, T. V., Healey, J. S., Israel, C. W., Kudaiberdieva, G., Levin, L.-Å., et al. (2017) · EP Europace · doi:10.1093/europace/eux163 · Cited by 247
Kirchhof, P., Lip, G. Y. H., Van Gelder, I. C., Bax, J., Hylek, E., Kaab, S., Schotten, U., Wegscheider, K., Boriani, G., Brandes, A., et al. (2012) · Europace · doi:10.1093/europace/eur241 · Cited by 243
Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation
Flaker, G., Lopes, R. D., Al-Khatib, S. M., Hermosillo, A. G., Hohnloser, S. H., Tinga, B., Zhu, J., Mohan, P., Garcia, D., Bartunek, J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.062 · Cited by 239
Atrial fibrillation in hypertrophie cardiomyopathy: A longitudinal study
Robinson, K., Frenneaux, M. P., Stockins, B., Karatasakis, G., Poloniecki, J. D., & Mckenna, W. J. (1990) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80014-2 · Cited by 237
Guo, Y., Chen, Y., Lane, D. A., Liu, L., Wang, Y., & Lip, G. Y. H. (2017) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.07.003 · Cited by 230
Integrated care for chronic conditions: The contribution of the ICCC Framework
Nuño, R., Coleman, K., Bengoa, R., & Sauto, R. (2012) · Health Policy · doi:10.1016/j.healthpol.2011.10.006 · Cited by 229
Tsang, T. S. M., Petty, G. W., Barnes, M. E., O’Fallon, W. M., Bailey, K. R., Wiebers, D. O., Sicks, J. D., Christianson, T. J. H., Seward, J. B., & Gersh, B. J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00500-x · Cited by 228
Capucci, A., Lenzi, T., Boriani, G., Trisolino, G., Binetti, N., Cavazza, M., Fontana, G., & Magnani, B. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91392-h · Cited by 228
Kirchhof, P., Blank, B. F., Calvert, M., Camm, A. J., Chlouverakis, G., Diener, H.-C., Goette, A., Huening, A., Lip, G. Y. H., Simantirakis, E., et al. (2017) · American Heart Journal · doi:10.1016/j.ahj.2017.04.015 · Cited by 227
Zhu, W., He, W., Guo, L., Wang, X., & Hong, K. (2015) · Clinical Cardiology · doi:10.1002/clc.22435 · Cited by 224
Chromosome 4q25 Variants and Atrial Fibrillation Recurrence After Catheter Ablation
Husser, D., Adams, V., Piorkowski, C., Hindricks, G., & Bollmann, A. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.11.041 · Cited by 218
Restarting Anticoagulation and Outcomes After Major Gastrointestinal Bleeding in Atrial Fibrillation
Qureshi, W., Mittal, C., Patsias, I., Garikapati, K., Kuchipudi, A., Cheema, G., Elbatta, M., Alirhayim, Z., & Khalid, F. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.10.044 · Cited by 218
Digoxin and Mortality in Patients With Atrial Fibrillation
Lopes, R. D., Rordorf, R., De Ferrari, G. M., Leonardi, S., Thomas, L., Wojdyla, D. M., Ridefelt, P., Lawrence, J. H., De Caterina, R., Vinereanu, D., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.12.060 · Cited by 217
Clemo, H. F., Wood, M. A., Gilligan, D. M., & Ellenbogen, K. A. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00962-4 · Cited by 215
Wireless smartphone ECG enables large-scale screening in diverse populations
HABERMAN, Z. C., JAHN, R. T., BOSE, R., TUN, H., SHINBANE, J. S., DOSHI, R. N., CHANG, P. M., & SAXON, L. A. (2015) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12634 · Cited by 212
McNamara, R. L., Tamariz, L. J., Segal, J. B., & Bass, E. B. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-12-200312160-00012 · Cited by 211
Familial Aggregation of Atrial Fibrillation: A Study in Danish Twins
Christophersen, I. E., Ravn, L. S., Budtz-Joergensen, E., Skytthe, A., Haunsoe, S., Svendsen, J. H., & Christensen, K. (2009) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.108.786665 · Cited by 209
Morton, J. B., Sanders, P., Vohra, J. K., Sparks, P. B., Morgan, J. G., Spence, S. J., Grigg, L. E., & Kalman, J. M. (2003) · Circulation · doi:10.1161/01.cir.0000058164.68127.f2 · Cited by 206
Self-citationDamiano, R. J., Gaynor, S. L., Bailey, M., Prasad, S., Cox, J. L., Boineau, J. P., & Schuessler, R. P. (2003) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2003.07.006 · Cited by 205
Perera, V., Bajorek, B. V., Matthews, S., & Hilmer, S. N. (2008) · Age and Ageing · doi:10.1093/ageing/afn293 · Cited by 204
Self-citationCOHEN, L. S., & BRAUNWALD, E. (1967) · Circulation · doi:10.1161/01.cir.35.5.847 · Cited by 203
SHAH, A. N., MITTAL, S., SICHROVSKY, T. C., COTIGA, D., ARSHAD, A., MALEKI, K., PIERCE, W. J., & STEINBERG, J. S. (2008) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2008.01101.x · Cited by 202
mHealth in Cardiovascular Health Care
Chow, C. K., Ariyarathna, N., Islam, S. M. S., Thiagalingam, A., & Redfern, J. (2016) · Heart, Lung and Circulation · doi:10.1016/j.hlc.2016.04.009 · Cited by 202
Lau, D. H., Mackenzie, L., Kelly, D. J., Psaltis, P. J., Brooks, A. G., Worthington, M., Rajendram, A., Kelly, D. R., Zhang, Y., Kuklik, P., et al. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.05.010 · Cited by 200
Self-citationIntegrated care in atrial fibrillation: a systematic review and meta-analysis
Gallagher, C., Elliott, A. D., Wong, C. X., Rangnekar, G., Middeldorp, M. E., Mahajan, R., Lau, D. H., Sanders, P., & Hendriks, J. M. L. (2017) · Heart · doi:10.1136/heartjnl-2016-310952 · Cited by 197
Self-citationCollins, K. K., Love, B. A., Walsh, E. P., Saul, J. P., Epstein, M. R., & Triedman, J. K. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01132-2 · Cited by 194
Rate control in atrial fibrillation
Van Gelder, I. C., Rienstra, M., Crijns, H. J. G. M., & Olshansky, B. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31258-2 · Cited by 193
Brodsky, M. A., Allen, B. J., Capparelli, E. V., Luckett, C. R., Morton, R., & Henry, W. L. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90079-9 · Cited by 192
Munger, T. M., Dong, Y.-X., Masaki, M., Oh, J. K., Mankad, S. V., Borlaug, B. A., Asirvatham, S. J., Shen, W.-K., Lee, H.-C., Bielinski, S. J., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.03.042 · Cited by 189
Clinical Classifications of Atrial Fibrillation Poorly Reflect Its Temporal Persistence
Charitos, E. I., Pürerfellner, H., Glotzer, T. V., & Ziegler, P. D. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.04.019 · Cited by 188 · cited 1×
“While classifying patterns of AF has some clinical value, it is often inaccurate and underestimates the temporal persistence of AF captured by continuous ECG monitoring [47].”
Does preoperative atrial fibrillation reduce survival after coronary artery bypass grafting?
Quader, M. A., McCarthy, P. M., Gillinov, A. M., Alster, J. M., Cosgrove, D. M., Lytle, B. W., & Blackstone, E. H. (2004) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2003.09.069 · Cited by 188
Van Gelder, I. C., Crijns, H. J. G. M., Van Gilst, W. H., Van Wijk, L. M., Hamer, H. P. M., & Lie, K. I. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90574-2 · Cited by 187
Aryana, A., Singh, S. K., Singh, S. M., Gearoid O’Neill, P., Bowers, M. R., Allen, S. L., Lewandowski, S. L., Vierra, E. C., & d’Avila, A. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.03.028 · Cited by 184
Chevalier, P., Durand-Dubief, A., Burri, H., Cucherat, M., Kirkorian, G., & Touboul, P. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02705-5 · Cited by 184
Cardiac sodium channel mutation in atrial fibrillation
Ellinor, P. T., Nam, E. G., Shea, M. A., Milan, D. J., Ruskin, J. N., & MacRae, C. A. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2007.09.015 · Cited by 180
Prevalence of early-onset atrial fibrillation in congenital long QT syndrome
Johnson, J. N., Tester, D. J., Perry, J., Salisbury, B. A., Reed, C. R., & Ackerman, M. J. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.02.007 · Cited by 179
Cited by
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström-Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P. E., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 9,971
Self-citationTzeis, S., Gerstenfeld, E. P., Kalman, J., Saad, E. B., Sepehri Shamloo, A., Andrade, J. G., Barbhaiya, C. R., Baykaner, T., Boveda, S., Calkins, H., et al. (2024) · Europace · doi:10.1093/europace/euae043 · Cited by 634
Self-citationTzeis, S., Gerstenfeld, E. P., Kalman, J., Saad, E. B., Shamloo, A. S., Andrade, J. G., Barbhaiya, C. R., Baykaner, T., Boveda, S., Calkins, H., et al. (2024) · Heart Rhythm · doi:10.1016/j.hrthm.2024.03.017 · Cited by 298
Self-citationBorre, E., Goode, A., Raitz, G., Shah, B., Lowenstern, A., Chatterjee, R., Sharan, L., Allen LaPointe, N., Yapa, R., Davis, J., et al. (2018) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1675400 · Cited by 229
Smartphones and wearable technology: benefits and concerns in cardiology
Jin, D., Adams, H., Cocco, A. M., Martin, W. G., & Palmer, S. (2020) · Medical Journal of Australia · doi:10.5694/mja2.50446 · Cited by 20
Metadata
- Authors
- Brieger, D., Amerena, J., Attia, J., Bajorek, B., Chan, K. H., Connell, C., Freedman, B., Ferguson, C., Hall, T., Haqqani, H., Hendriks, J., Hespe, C., Hung, J., Kalman, J. M., Sanders, P., Worthington, J., Yan, T. D., & Zwar, N.
- Venue
- Heart, Lung and Circulation
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 27
- Issue
- 10
- Pages
- 1209-1266
- ISSN
- 1443-9506 (ISSN-L)
- OpenAlex
- W3107986792
- Cited by
- 327
- References
- 381
- FWCI
- 25.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.